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ABSTRACT: N-arylated α-amino acids and pyrazolidin-3-
ones are widely being used as chiral building blocks for
pharmaceuticals and agrochemicals. Here we report a
biocatalytic route for the asymmetric synthesis of various N-
arylated aspartic acids applying ethylenediamine-N,N′-dis-
uccinic acid lyase (EDDS lyase) as a biocatalyst. This enzyme
shows a broad substrate scope, enabling the addition of a
variety of arylamines to fumarate with high conversions, yielding the corresponding N-arylated aspartic acids in good isolated
yields and with high enantiomeric excess (ee > 99%). Furthermore, we developed a chemoenzymatic method toward the
synthetically challenging chiral 2-aryl-5-carboxylpyrazolidin-3-ones, using arylhydrazines as bis-nucleophilic donors in the EDDS
lyase catalyzed hydroamination of fumarate followed by an acid-catalyzed intramolecular amidation, achieving good overall
yields and high optical purity (ee > 99%). In addition, we successfully combined the EDDS lyase catalyzed hydroamination and
acid-catalyzed cyclization steps in one pot, thus providing a simple chemoenzymatic cascade route for synthesis of
enantiomerically pure pyrazolidin-3-ones. Hence, these biocatalytic methods provide convenient alternative routes to important
chiral N-arylated aspartic acids and diﬃcult 2-aryl-5-carboxylpyrazolidin-3-ones.
KEYWORDS: asymmetric synthesis, biocatalysis, EDDS lyase, unnatural amino acids, pyrazolidinones, cascade synthesis
■ INTRODUCTION
Optically pure functionalized α-amino acids are highly valuable
as tools for biological research and as chiral building blocks for
pharmaceuticals, nutraceuticals, and agrochemicals.1−3 In
particular, N-arylated α-amino acids are part of the core
structures of a number of medicinally important agents, such as
the ﬁbrinogen receptor antagonist Lotraﬁban (1, Figure 1a)4
and protein kinase C activator Indolactam-V (2, Figure 1a).5,6
Despite their broad applications, the direct synthesis of chiral
N-arylated α-amino acids remains a challenge. Current
chemical strategies for the synthesis of enantioenriched N-
arylated α-amino acids and their esters are mainly based on
extending the existing free amino group of the Cα stereocenter
through Cu-catalyzed Ullmann-type coupling reactions,6−9 Pd-
catalyzed N-arylation,10−13 and hypervalent iodine chemistry
(Figure 1a).14 However, these strategies are limited by their
poor atom economy, the use of heavy metals, and harsh
reaction conditions that may result in partial or complete
racemization of the α-stereocenter. Biocatalysis provides a
valuable alternative route to chiral unnatural amino acids.15−18
Previously reported enzymatic asymmetric synthesis of N-alkyl-
functionalized α-amino acids were primarily based on two
types of carbon−nitrogen bond-forming reactions: (i)
conjugate addition of amines to the double bond of α,β-
unsaturated acids catalyzed by various types of carbon−
nitrogen lyases, including aspartate ammonia lyases (aspar-
tases),19,20 methylaspartate ammonia lyases (MALs),21,22 and
the recently reported ethylenediamine-N,N′-disuccinic acid
lyase (EDDS lyase),23,24 and (ii) reductive amination of α-keto
acids with amines catalyzed by a number of oxidoreductases,
such as reductive aminase (RedAm),25 opine dehydrogenases
(OpDHs),26,27 N-methylamino acid dehydrogenases
(NMAADHs),28,29 ketimine reductases (KIREDs),29,30 and
Δ1-pyrroline-5-carboxylate reductases (P5CRs).29,31 However,
to the best of our knowledge, no enzymatic route has been
reported for the synthesis of N-aryl-functionalized α-amino
acids. Thus, the development of an eﬃcient and sustainable
biocatalytic methodology to enantiomerically pure N-arylated
α-amino acid derivatives would be particularly desirable.
Pyrazolidin-3-ones and related ﬁve-membered dinitrogen-
fused heterocycles are widely found as the core framework in
dyes, agrochemicals, and pharmaceutically active molecules,
such as the very ﬁrst synthetic analgesic and antipyretic drug
Phenazone (3, Figure 1b),32 lipoxygenase inhibitor Phendione
(4, Figure 1b),33 and anti-Alzheimer agents (5, Figure 1b).34
In addition, chiral pyrazolidin-3-ones can also function as
eﬃcient catalysts in promoting Diels−Alder reactions35 and
catalyze the kinetic resolution of secondary alcohols and axially
chiral biaryl compounds.36 Due to their broad application in
drug development, as well as in synthetic methodologies,
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several chemical methods have been developed for the
synthesis of enantiomerically pure pyrazolidinones and related
heterocycles, including chemical35,37 or kinetic resolution,38
1,3-dipolar cycloaddition,39−41 Lewis acid catalyzed conjugate
addition,42 and Pd-catalyzed asymmetric hydrogenation.43
However, creating a biocatalytic methodology as an alternative
route to chiral pyrazolidinones is an as yet unmet challenge.
The enzyme ethylenediamine-N,N′-disuccinic acid lyase
(EDDS lyase), from Chelativorans sp. BNC1, naturally
catalyzes a reversible two-step sequential addition of ethyl-
enediamine to two molecules of fumarate, providing (S,S)-
EDDS as the ﬁnal product (Figure 2a).44 We recently
demonstrated that EDDS lyase could accept a wide variety
of amino acids with terminal amino groups for regio- and
stereoselective addition to fumarate, providing the natural
Figure 1. Synthetic strategies for preparation of noncanonical amino acids that are part of the core structures of biologically active compounds: (a)
biologically active molecules containing an N-arylated amino acid (left panel), and previous synthetic strategies and our biocatalytic strategy toward
N-arylated aspartic acids (right panel); (b) biologically active molecules containing pyrazolidin-3-one (left panel), and established synthetic
strategies and our chemoenzymatic route toward pyrazolidin-3-ones (right panel).
Figure 2. Overview of reactions catalyzed by EDDS lyase: (a) natural reaction catalyzed by EDDS lyase; (b) EDDS lyase catalyzed asymmetric
addition of amino acids and (hetero)cycloalkyl-substituted amines to fumaric acid to yield complex aminocarboxylic acids and N-cycloalkyl-
substituted aspartic acids, respectively; (c) exploration of the arylamine and arylhydrazine scope of EDDS lyase for the (chemo)enzymatic
asymmetric synthesis of N-arylated aspartic acids and pyrazolidinones, respectively.
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product aspergillomarasmine A and various related amino-
carboxylic acids (Figure 2b).23 In addition, EDDS lyase could
also accept a number of (hetero)cycloalkyl-substituted amines,
allowing the asymmetric synthesis of (S)-N-cycloalkyl-sub-
stituted aspartic acids (Figure 2b).24 Therefore, the remarkably
broad nucleophile scope of EDDS lyase prompted us to further
explore the less nucleophilic arylamines as novel non-natural
substrates in the asymmetric hydroamination of fumarate,
which would enable the production of chiral N-arylated
aspartic acids as the corresponding enzymatic products (Figure
2c). Moreover, we envisioned that chiral pyrazolidin-3-ones
could be constructed by using arylhydrazines as bis-
nucleophilic donors in the EDDS lyase catalyzed regio- and
stereoselective addition to fumarate followed by a simple
intramolecular amidation (Figure 2c).
Herein, we report a biocatalytic methodology for the
synthesis of optically pure (S)-N-arylated aspartic acids in
high conversions and isolated yields. Moreover, an eﬃcient
one-pot, two-step chemoenzymatic route toward chiral
pyrazolidin-3-ones has been developed. These strategies
highlight a highly regio- and stereoselective hydroamination
step catalyzed by EDDS lyase, oﬀering alternative synthetic
choices to prepare chiral N-arylated α-amino acids as well as
chiral pyrazolidin-3-ones.
■ RESULTS
Biocatalytic Synthesis of N-Arylated Aspartic Acids.
In contrast to aliphatic amines, aromatic amines are
challenging substrates for biocatalytic addition reactions due
to their relatively low nucleophilicity. Our previous study
demonstrated that EDDS lyase could accept glycine as an
unnatural substrate, facilitating the low nucleophilic α-amino
group of glycine to function as the nucleophile in the
amination of fumarate (6).23 This prompted us to start our
investigation by testing aniline (7a, Table 1, entry 1) as a
potential substrate in the EDDS lyase catalyzed biotransforma-
tion. Remarkably, aniline (7a) was eﬃciently converted by
puriﬁed EDDS lyase to aﬀord N-phenyl-substituted aspartic
acid (8a) with high conversion (91%) and good isolated yield
(80%) using only 0.05 mol % biocatalyst loading under the
optimized conditions (Table 1). To determine the stereo-
chemistry of enzymatic product 8a, HPLC analysis on a chiral
stationary phase was conducted by using chemically prepared
authentic standards with known R/S and S conﬁgurations
(Figure S89). This analysis revealed that product 8a was
present as a single S-conﬁgured enantiomer with excellent
enantiomeric excess (ee > 99%, Table 1, entry 1).
Next, the substrate scope was investigated by examining a
panel of electronically diverse substituted anilines and
heteroarylamines as unnatural substrates in the EDDS lyase
catalyzed amination of fumarate, as monitored by 1H NMR
spectroscopy (Table S1). We were pleased to ﬁnd that EDDS
lyase displayed a broad arylamine substrate scope which was, as
expected, aﬀected by the electron-withdrawing/-donating
nature, position, and bulkiness of the substituents on the
aromatic ring (Table 1 and Table S1). Clearly, substitution of
the aromatic ring at the ortho position was not tolerated by the
enzyme, for which only o-ﬂuoroaniline (7b) gave a very low
conversion (6%; Table 1 and Table S1). Impressively,
arylamines with meta substituents, including m-ﬂuoroaniline
(7c), m-toluidine (7d), and m-methoxyaniline (7e), were
eﬃciently accepted by EDDS lyase providing the respective
products 8c−e (Table 1, entries 3−5). High conversions (87−
97%), good isolated product yields (53−84%), and excellent
stereoselectivity (ee > 99%) were observed (Table 1, entries
3−5). Similarly, para-substituted arylamines, such as p-
ﬂuoroaniline (7f), p-toluidine (7g), p-methoxyaniline (7h),
p-ethylaniline (7i), m,p-dimethylaniline (7j), and p-carbox-
ylaniline (7k), were also well accepted by the enzyme, giving
high to excellent conversions (75−95%) and yielding the
corresponding amino acids 8f−k (34−85% isolated yields) as
the S-conﬁgured enantiomers with >99% ee (Table 1, entries
6−11). It is worth noting that para-halogenated anilines (7l−
n) were also processed to deliver chiral (S)-N-haloarylaspartic
acids (8l−n) with 82−96% conversions and 52−69% isolated
yields (ee > 99% in all cases, Table 1, entries 12−14), leaving
the halogens available for potential downstream synthetic
manipulation. The larger nucleophile p-isopropylaniline (7o)
was a poor substrate for EDDS lyase, resulting in low
conversion (17%, Table 1, entry 15). Arylamines bearing a
strongly electron withdrawing group (such as p-nitro or p-CF3)
or electron-deﬁcient heteroarylamines (such as pyridin-2-
Table 1. Enzymatic Synthesis of (S)-N-Arylated Aspartic
Acidsa




(yieldc) (%) eed (%)
1 7a 8a H 48 91 (80) >99 (S)f
2 7b 8b o-F 72 6 (nde)
3 7c 8c m-F 48 91 (53) >99 (S)g
4 7d 8d m-Me 24 97 (84) >99 (S)g
5 7e 8e m-OMe 48 87 (53) >99 (S)g
6 7f 8f p-F 24 92 (85) >99 (S)f
7 7g 8g p-Me 48 75 (57) >99 (S)f
8 7h 8h p-OMe 48 92 (75) >99 (S)f
9 7i 8i p-Et 48 76 (53) >99 (S)g
10 7j 8j m,p-Me2 72 90 (70) >99 (S)
g
11 7k 8k p-CO2H 24 95 (34) >99 (S)
g
12 7l 8l p-Cl 48 96 (63) >99 (S)g
13 7m 8m p-Br 48 95 (69) >99 (S)f
14 7n 8n p-I 48 82 (52) >99 (S)g
15 7o 8o p-iPr 72 17 (nde)
aConditions and reagents: the reaction mixture (15 mL) consisted of
fumaric acid (6, 50 mM), arylamine substrates 7a−o (10 mM), and
puriﬁed EDDS lyase (0.05 mol % based on arylamine) in buﬀer (50
mM NaH2PO4/NaOH, pH 8.5), with 5% DMSO as cosolvent at
room temperature. A 5-fold excess of 6 (rather than an excess of
amine) was used to drive amine 7 to completion, simplifying product
puriﬁcation and preventing enzyme inhibition by a high concentration
of amine substrate. bConversions were determined by comparing 1H
NMR signals of substrates and corresponding products. cIsolated yield
after cation-exchange chromatography. dThe enantiomeric excess (ee)
was determined by HPLC on a chiral stationary phase using racemic
standards. eNot determined owing to low conversion. The product
formation was conﬁrmed by comparison of 1H NMR data of a crude
reaction mixture to those of a chemically prepared reference
compound. fThe absolute conﬁgurations of 8a,f−h,m were
determined by chiral HPLC using chemically synthesized authentic
standards with known R/S and S conﬁgurations, respectively. gThe
absolute conﬁgurations of 8c−e,i−l,n were tentatively assigned the S
conﬁguration on the basis of analogy and according to chiral HPLC
data.
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amine, pyridin-4-amine, and thiazol-2-amine) were not
accommodated as substrates by EDDS lyase, most likely due
to their diminished nucleophilicity (Table S1).
Chemoenzymatic Synthesis of Chiral Pyrazolidin-3-
ones. Enantioselective conjugate addition of bis-nucleophilic
donors (such as hydrazines) to electron-poor acceptors
provides convenient access to valuable small-ring heterocycles
with potential pharmaceutical applications.32−34,42 Encouraged
by the exquisite stereoselectivity of the EDDS lyase catalyzed
biotransformation accepting a broad range of arylamines (7,
Table 1), we further questioned whether bis-nucleophilic
arylhydrazines (9, Table 2) could be processed as substrates by
this enzyme in the amination of fumarate (6). Not only are the
corresponding enzymatic products, N-(arylamino)aspartic
acids (10), valuable scaﬀolds in their own right but they also
could serve as chiral precursors for the preparation of
synthetically challenging chiral pyrazolidin-3-ones (11)
through an acid-catalyzed cyclization reaction (Table 2).
Remarkably, phenylhydrazine (9a), as the ﬁrst chosen potential
bis-nucleophilic substrate, was eﬃciently converted by EDDS
lyase (0.1 mol %) to aﬀord the single product N-
(phenylamino)aspartic acid (10a), as ascertained by 1H
NMR in comparison with a chemically prepared authentic
standard. In the enzymatic semipreparative synthesis (0.20
mmol scale) of compound 10a, excellent conversion (94%)
and good isolated yield (80%, 36 mg) were achieved (Table 2,
entry 1). Note that it is necessary to perform the enzymatic
reaction under anaerobic conditions; otherwise, the substrate
phenylhydrazine could be oxidized by molecular oxygen and
thus lead to diminished conversion. Subsequently, the
enzymatic product 10a was cyclized smoothly under optimized
conditions (1 M HCl, reﬂux for 3 h),37 aﬀording the desired
heterocycle 2-phenyl-5-carboxylpyrazolidin-3-one (11a, 71%
isolated yield) without racemization of the potentially sensitive
Cα stereogenic center (ee > 99%, Table 2, entry 1). The
chemoenzymatically prepared heterocycle 11a was identiﬁed as
the S-conﬁgured enantiomer by chiral HPLC analysis (Figure
S102).
To further illustrate the synthetic usefulness of this
chemoenzymatic method, we ﬁrst determined that EDDS
lyase has a broad substrate scope with respect to arylhydrazines
(9), enabling the addition of various arylhydrazines to
fumarate (Table S2). Pleasingly, several arylhydrazines with
an ortho substituent (o-ﬂuoro, 9b) or meta substituent (such
as m-ﬂuoro, m-methyl, and m-chloro, 9c−e) were eﬃciently
converted by EDDS lyase, giving the respective enzymatic
products 10b−e with excellent conversions (92−98%) and
good isolated yields (76−85%, Table 2, entries 2−5). Notably,
a number of arylhydrazines containing para substituents, such
as p-ﬂuoro, p-chloro, p-bromo, p-cyano, p-methyl, and p-
carboxyl (9f−k), were also well accepted by the enzyme, giving
the corresponding N-(arylamino)aspartic acids (10f−k) in
high to excellent conversions (71−97%) and 52−89% isolated
yields (Table 2, entries 6−11). However, p-(methoxyphenyl)-
hydrazine (9l) was not well accepted by EDDS lyase with
unsatisfactory conversion (28%, Table 2, entry 12); the reason
for the low conversion of this substrate is not known.
Typically, arylhydrazines containing a strongly electron
withdrawing group at the aromatic ring (namely p-nitro or p-
CF3) or a bulky naphthalen-2-yl group failed to undergo the
EDDS lyase catalyzed hydroamination reaction (Table S2).
Table 2. Chemoenzymatic Synthesis of Chiral Pyrazolidin-3-onesa
ﬁrst enzymatic step second cyclization step
entry arylhydrazine R intermediate conversnb (yieldc) (%) product yieldc (%) eee (%) overall yield (%)i
1 9a H 10a 94 (80) 11a 71 >99 (S)f 57
2 9b o-F 10b 98 (81) 11b 46 >99 (S)g 37
3 9c m-F 10c 98 (83) 11c 73 >99 (S)f 61
4 9d m-Me 10d 92 (76) 11d 62 >99 (S)f 47
5 9e m-Cl 10e 98 (85) 11e 67 >99 (S)f 57
6 9f p-F 10f 85 (52) 11f 59 >99 (S)f 31
7 9g p-Cl 10g 80 (68) 11g 80 >99 (S)f 54
8 9h p-Br 10h 91 (81) 11h 76 >99 (S)f 62
9 9i p-CN 10i 92 (70) 11i 57 >99 (S)g 40
10 9j p-Me 10j 71 (63) 11j 58 >99 (S)f 37
11 9k p-CO2H 10k 97 (89) 11k 69 nd
h 61
12 9l p-OMe 10l 28 (ndd) 11l
aConditions and reagents: the reaction mixture (20 mL) consisted of fumaric acid (6, 50 mM), arylhydrazine substrates 9a−l (10 mM), and
puriﬁed EDDS lyase (0.1 mol % based on arylhydrazine; the amount of applied enzyme was chosen such that reactions were completed within 24−
96 h) in degassed buﬀer (50 mM NaH2PO4/NaOH, pH 8.5) under an argon atmosphere at room temperature (24 h for 10k; 48 h for 10a,c,e,h−i;
96 h for 10b,d,f,g,j,l). bConversions were determined by comparing 1H NMR signals of substrates and corresponding products. cIsolated yield after
puriﬁcation. dNot determined owing to low conversion. The product formation was conﬁrmed by comparison of 1H NMR data of a crude reaction
mixture to those of a chemically prepared reference compound. eEnantiomeric excess (ee) was determined by HPLC on a chiral stationary phase
using chemically synthesized racemic standards. fThe absolute conﬁgurations of 11a,c−h,j were determined by chiral HPLC using authentic
standards with known R/S and S conﬁgurations. gThe absolute conﬁgurations of 11b,i were tentatively assigned the S conﬁguration on the basis of
analogy and according to chiral HPLC data. hThe ee value was not determined. iIsolated yield over two steps.
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With the precious enzymatically prepared intermediates
(10b−k) in hand, we subsequently performed the acid-
catalyzed cyclization reaction to achieve the target 2,5-
disubstituted pyrazolidin-3-one products. Remarkably, all of
the intermediates (10b−k) could be cyclized smoothly under
the optimized conditions to provide the desired pyrazolidin-3-
ones (11b−k) with good isolated yield (46−80%, Table 2,
entries 2−11). Moreover, all of the tested chemoenzymatic
products (11b−k) were assigned the S conﬁguration, with
excellent enantiomeric excess (ee > 99%, Table 2, entries 2−
11), using chiral HPLC analysis (Figures S103−S111). As
such, we have established an eﬃcient two-step chemo-
enzymatic route toward chiral 2-aryl-5-carboxylpyrazolidin-3-
ones (11a−k) with good overall yields and excellent
stereoselectivity (ee > 99%).
One-Pot Chemoenzymatic Synthesis of Chiral Pyr-
azolidin-3-ones. Having established a stepwise chemo-
enzymatic route toward chiral pyrazolidin-3-ones (11), we
sought to combine the EDDS lyase catalyzed biotransforma-
tion and acid-catalyzed cyclization into one pot (Figure 3). In
order to achieve a high overall yield, as well as to eﬀect the
second cyclization step in the one-pot synthesis of pyrazolidin-
3-ones (11), high conversion of the starting arylhydrazine
substrates 9 in the ﬁrst enzymatic step is required, preventing it
from reacting with the intermediate 10 during the subsequent
acid-promoted amidation step. Toward this end, the substrate
phenylhydrazine (9a) that could be eﬃciently converted by
EDDS lyase with 94% conversion was chosen for our initial
investigation to provide the corresponding intermediate 10a
(Table 2 and Figure 3). Without any puriﬁcation, intermediate
10a was subjected to cyclization in the same pot, to which
fuming hydrochloric acid (HCl) was added to adjust the ﬁnal
concentration of HCl to 1 M, providing full conversion for the
second cyclization step after heating to reﬂux for 3 h.
Pleasingly, the one-pot chemoenzymatically prepared product
(S)-2-phenyl-5-carboxylpyrazolidin-3-one (11a) was isolated
with good overall yield (68%) and excellent optical purity (ee
> 99%, Figure 3).
To further demonstrate the synthetic usefulness of this one-
pot two-step chemoenzymatic strategy, we selected ﬁve other
starting arylhydrazines (9c−e,h,i, Table 2), which proved to be
well accepted as substrates by EDDS lyase. The corresponding
chemoenzymatically prepared (S)-pyrazolidin-3-one deriva-
tives (11c−e,h,i) were obtained with good overall isolated
yields (61−70%) and excellent enantiopurity (ee > 99% in all
cases, Figure 3). Therefore, this one-pot chemoenzymatic
synthesis route provides a simpliﬁed practical procedure
toward optically pure pyrazolidin-3-ones with higher overall
isolated yields.
■ DISCUSSION
In contrast to previously reported chemical synthesis strategies
for preparation of enantioenriched N-arylated α-amino acids,
such as metal-catalyzed N-arylation7−13 or hypervalent iodine
chemistry,14 which mainly depend on extending the free amino
group of the starting chiral α-amino acids (or their esters), our
biocatalytic method starts with a prochiral α,β-unsaturated acid
(fumarate) and creates the Cα stereocenter of the target N-
arylated amino acids in a single asymmetric step with excellent
stereocontrol (Figure 1a). We demonstrated that EDDS lyase
shows a broad scope of anilines, enabling the addition of a
variety of aromatic amines (7a−n) to fumarate, yielding
optically pure (ee > 99%) (S)-N-arylated aspartic acids (8a−n)
with high conversions and in good isolated yields (Table 1).
Furthermore, we discovered that EDDS lyase can accept a wide
Figure 3. One-pot, two-step chemoenzymatic synthesis of chiral pyrazolidin-3-ones. Reagents and reaction conditions: (a) arylhydrazine substrates
9 (10 mM), fumaric acid (6, 50 mM), and puriﬁed EDDS lyase (0.1 mol % based on arylhydrazine) in degassed buﬀer (50 mM NaH2PO4/NaOH,
pH 8.5) under an argon atmosphere at room temperature (48 h for 9a,c,e,h,i; 96 h for 9d); (b) 1 M HCl, reﬂux for 3 h under nitrogen atmosphere;
(c) isolated yield over two steps; (d) enantiomeric excess (ee) determined by HPLC on a chiral stationary phase using chemically synthesized
racemic standards; (e) absolute conﬁgurations of the one-pot chemoenzymatic products 11a,c−e,h determined by chiral HPLC analysis using
authentic standards with known R/S and S conﬁgurations, absolute conﬁguration of product 11i tentatively assigned the S conﬁguration on the
basis of analogy and according to chiral HPLC data.
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range of arylhydrazines (9a−k) in the hydroamination of
fumarate, yielding the corresponding N-(arylamino)-substi-
tuted aspartic acids (10a−k) with high conversions and in
good isolated yields (Table 2). Subsequently, these enzymatic
products (10a−k) could undergo a smooth acid-catalyzed
cyclization to give the synthetically challenging chiral (S)-
pyrazolidin-3-one derivatives 11a−k with excellent enantio-
meric excess (ee > 99%, Table 2). In addition, we successfully
combined the EDDS lyase catalyzed biotransformation and
acid-catalyzed cyclization into one pot, thus providing a rather
simple two-step chemoenzymatic route for the rapid synthesis
of optically pure pyrazolidin-3-ones with good overall isolated
yields (Figure 3).
Enantioselective addition of ammonia or amines to the
appropriate α,β-unsaturated carboxylic acids catalyzed by
carbon−nitrogen lyases represents an attractive strategy for
the synthesis of chiral unnatural amino acids. This enzymatic
strategy makes use of readily available prochiral α,β-
unsaturated acids as the starting substrates without a
requirement for cofactor recycling, circumvents tedious steps
of protecting or activating carboxylic groups, gives 100%
theoretical yield, and normally provides high stereoselectivity
under mild and potentially green reaction conditions. Several
synthetically useful carbon−nitrogen lyases, such as aspartate
ammonia lyases (DALs),16,17,20,45 methylaspartate ammonia
lyases (MALs),16,17,21,46 phenylalanine ammonia lyases
(PALs),16,17 and phenylalanine aminomutases (PAMs),16,17
were successfully used in the synthesis of optically pure
unnatural α- or β-amino acids. However, with the exception of
an engineered mutant of MAL (MAL-Q37A), which accepts
various alkylamines as substrates in the addition to
mesaconate,21 these enzymes display a rather limited
nucleophile scope. In contrast, EDDS lyase has a very broad
nucleophile scope, accepting a wide variety of structurally
distinct amines for stereoselective addition to fumarate,
providing enzymatic access to various aminocarboxylic acids
including the natural products toxin A, aspergillomarasmine A,
and aspergillomarasmine B,23 N-cycloalkyl-substituted aspartic
acids,24 and diﬃcult N-arylated aspartic acid derivatives and
substituted pyrazolidin-3-ones (this study, Figure 2). As such,
EDDS lyase nicely complements the biocatalytic toolbox for
the preparation of noncanonical amino acids. In future work,
we will focus our attention on extending the electrophile scope
of EDDS lyase, which was found to be highly speciﬁc for
fumarate with other α,β-unsaturated carboxylic acids (includ-
ing crotonic acid, mesaconic acid, itaconic acid, and 2-
pentenoic acid) not being accepted as alternative electro-
philes,44 by computational design and structure-guided protein
engineering.
■ METHODS
Enzymatic Synthesis of (S)-N-Arylated Aspartic Acids
(8a−n). Enzyme expression and puriﬁcation were performed
according to procedures described elsewhere (see the
Supporting Information).23,44 The reaction mixture (15 mL)
consisted of fumaric acid (50 mM) and an arylamine substrate
(7a−n, 10 mM) in 50 mM NaH2PO4−NaOH buﬀer (pH 8.5)
with 5% DMSO as cosolvent. The pH of the reaction mixture
was adjusted to pH 8.5. The enzymatic reaction was started by
addition of freshly puriﬁed EDDS lyase (0.05 mol %). The
reaction mixture was then incubated at room temperature from
24 to 72 h (Table 1). After completion of the reaction, the
enzyme was inactivated by heating to 70 °C for 10 min. The
progress of the enzymatic reaction was monitored by 1H NMR
spectroscopy by comparing the signals of substrates and
corresponding products.
The amino acid products were puriﬁed by cation-exchange
chromatography. For a typical puriﬁcation procedure, the
precipitated enzyme was removed by ﬁltration (pore diameter
0.45 μm). The ﬁltrate was washed with ethyl acetate (10 mL ×
3) to remove the remaining amines. The aqueous layer was
acidiﬁed with 1 M HCl to pH 1 and loaded slowly onto a
cation-exchange column (5 g of Dowex 50W X8 resin, 100−
200 mesh), which was pretreated with 2 M aqueous ammonia
(5 column volumes), 1 M HCl (3 column volumes), and
ﬁnally water (5 column volumes). The column was washed
with water (3 column volumes) to remove the remaining
fumaric acid and eluted with 2 M aqueous ammonia until the
desired product was collected. The ninhydrin-positive fractions
were collected, concentrated under vacuum, and lyophilized to
provide the desired products (8a−n) as ammonium salts.
One-Pot Chemoenzymatic Synthesis of Pyrazolidin-
3-ones (11). Step 1. The reaction mixture (20 mL) consisted
of fumaric acid (50 mM) and an arylhydrazine substrate (9, 10
mM) in 50 mM NaH2PO4−NaOH degassed buﬀer (pH 8.5)
under an argon atmosphere. The pH of the reaction mixture
was adjusted to pH 8.5. The enzymatic reaction was started by
addition of freshly puriﬁed EDDS lyase (0.1 mol %). The
reaction mixture was then incubated at room temperature from
48 to 96 h (Figure 3). The progress of the enzymatic reaction
was monitored by 1H NMR spectroscopy by comparing the
signals of substrates and corresponding products. Without
puriﬁcation of the enzymatic product 10, the reaction mixture
was subjected to the next step immediately.
Step 2. To the stirred reaction mixture from the previous
step was added 1.6 mL of fuming hydrochloric acid dropwise
with cooling (ice bath). After 5 min, the reaction mixture was
heated to reﬂux for 3 h under a nitrogen atmosphere. After
completion of the reaction, the reaction mixture was cooled to
room temperature. The reaction mixture was extracted with
EtOAc (20 mL × 3), and washed with brine (30 mL). The
solvent was evaporated to provide crude product 11, which
was puriﬁed by C18 column chromatography (5−50% CH3CN
in H2O as the eluent).
All data are available from the corresponding author upon
reasonable request. Correspondence and requests for materials
should be addressed to G.J.P.
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